Clinical Trial Update: A Study of the Pharmacokinetics, Safety and Tolerability of Single Doses of VR647 Inhalation Suspension Administered Using the VR647 Inhalation System in Children With Wheezing, Reactive Airway Disease or Mild Asthma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics, safety, and tolerability of single doses of VR647 inhalation suspension in children with wheezing, reactive airway di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Reactive Airway Disease
• Wheezing

Drugs mentioned

• VR647 inhalation suspension

Snippet

Sponsor: Vectura Limited | Conditions: Wheezing, Reactive Airway Disease | Phase 1 | Status: COMPLETED | Results posted: 2019-10-21